The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
Open accessAbstract
Apoptosis occurs in the normal liver and in various forms of liver disease. The CD95 (APO-1/Fas) (CD95) receptor mediates apoptosis, and liver cells in animal models are acutely sensitive to apoptosis initiated by this receptor. We have used primary human hepatocytes as a model system to investigate CD95-mediated apoptotic liver damage. Treatment of fresh human hepatocytes with low concentrations of agonistic antibodies against CD95 resulted in apoptosis of > 95% of the cultured liver cells within 4 and 7.5 h. Immunohistology of a panel of explanted liver tissues revealed that hepatocytes in normal livers (n = 5) and in alcoholic cirrhosis (n = 13) expressed low constitutive levels of CD95. CD95 receptor expression was highly elevated in hepatocytes in hepatitis B virus-related cirrhosis (n = 9) and in acute liver failure (n = 8). By in situ hybridization CD95 ligand messenger RNA expression was absent in normal liver but detected at high levels in livers with ongoing liver damage. In cases of hepatitis B virus-related cirrhosis and acute hepatic failure, ligand expression was found primarily in areas with lymphocytic infiltration. In contrast, in patients with alcoholic liver damage, high CD95 ligand messenger RNA expression was found in hepatocytes. These findings suggest that liver destruction in hepatitis B may primarily involve killing of hepatocytes by T lymphocytes using the CD95 receptor-ligand system. In alcoholic liver damage, death of hepatocytes might occur by fratricide and paracrine or autocrine mechanisms mediated by the hepatocytes themselves.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications
Freshney, R. I. (2010) · Wiley eBooks · doi:10.1002/9780470649367 · Cited by 3,870
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,887
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Möller, P., Falk, W., Debatin, K.-M., & Krammer, P. H. (1989) · Science · doi:10.1126/science.2787530 · Cited by 1,716
Self-citationAutocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M., & Krammer, P. H. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,609
Self-citationGeneralized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,528
Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity
Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Depraetere, V., Nagata, S., Hengartner, H., & Golstein, P. (1994) · Science · doi:10.1126/science.7518614 · Cited by 1,516
Yonehara, S., Ishii, A., & Yonehara, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.5.1747 · Cited by 1,400
Culture of Animal Cells: A Manual of Basic Technique
(1985) · Food and Chemical Toxicology · doi:10.1016/0278-6915(85)90082-1 · Cited by 1,249
Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
Lowin, B., Hahne, M., Mattmann, C., & Tschopp, J. (1994) · Nature · doi:10.1038/370650a0 · Cited by 1,051
Acute liver failure: redefining the syndromes
Williams, R., Schalm, S. W., & O'Grady, J. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)91818-7 · Cited by 966
Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., & Trauth, B. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50076-x · Cited by 834
Heusel, J. W., Wesselschmidt, R. L., Shresta, S., Russell, J. H., & Ley, T. J. (1994) · Cell · doi:10.1016/0092-8674(94)90376-x · Cited by 812
Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.
Rouvier, E., Luciani, M. F., & Golstein, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.195 · Cited by 787
An evolutionary perspective on apoptosis
Vaux, D. L., Haecker, G., & Strasser, A. (1994) · Cell · doi:10.1016/0092-8674(94)90350-6 · Cited by 756
Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K., Krammer, P. H., & Möller, P. (1993) · PubMed · Cited by 625
Self-citationPurification and characterization of the Fas-ligand that induces apoptosis.
Suda, T., & Nagata, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.873 · Cited by 507
Culture of animal cells: A manual of basic technique
Borek, F. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)90024-1 · Cited by 501
Human Fas ligand: gene structure, chromosomal location and species specificity
Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T., & Nagata, S. (1994) · International Immunology · doi:10.1093/intimm/6.10.1567 · Cited by 434
Cell death by apoptosis and its protective role against disease
Bursch, W., Oberhammer, F., & Schulte-Hermann, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90077-j · Cited by 426
Programmed cell death, apoptosis and killer genes
Schwartz, L. M., & Osborne, B. A. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90197-s · Cited by 385
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
Stalder, T., Hahn, S., & Erb, P. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1127 · Cited by 373
White, E., Sabbatini, P., Debbas, M., Wold, W. S. M., Kusher, D. I., & Gooding, L. R. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2570-2580.1992 · Cited by 349
The mouse fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster
Lynch, D. H., Watson, M. L., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., Gibson, M., Davis-Smith, T., Smiths, C. A., Hunter, K., et al. (1994) · Immunity · doi:10.1016/1074-7613(94)90106-6 · Cited by 331
Nayersina, R., Fowler, P., Guilhot, S., Missale, G., Cerny, A., Schlicht, H. J., Vitiello, A., Chesnut, R., Person, J. L., Redeker, A. G., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.10.4659 · Cited by 330
Regulation of apoptosis in the immune system
Krammer, P. H., Behrmann, I., Daniel, P., Dhein, J., & Debatin, K.-M. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90102-3 · Cited by 308
Self-citationJu, S. T., Cui, H., Panka, D. J., Ettinger, R., & Marshak-Rothstein, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4185 · Cited by 296
Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity.
Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, N., Matsuzawa, A., Nishimura, Y., Kobayashi, Y., Yonehara, S., Yagita, H., & Okumura, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4930 · Cited by 280
Dhein, J., Daniel, P. T., Trauth, B. C., Oehm, A., Möller, P., & Krammer, P. H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.10.3166 · Cited by 278
Self-citationUrsodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes
Galle, P. R., Theilmann, L., Raedsch, R., Otto, G., & Stiehl, A. (1990) · Hepatology · doi:10.1002/hep.1840120307 · Cited by 247
Self-citationFas-Mediated Apoptosis in Primary Cultured Mouse Hepatocytes
Ni, R., Tomita, Y., Matsuda, K., Ichihara, A., Ishimura, K., Ogasawara, J., & Nagata, S. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1349 · Cited by 199
Anel, A., Buferne, M., Boyer, C., Schmitt‐Verhulst, A., & Golstein, P. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241032 · Cited by 197
Role of Fas Ligand in Apoptosis Induced by Hepatitis C Virus Infection
Mita, E., Hayashi, N., Iio, S., Takehara, T., Hijioka, T., Kasahara, A., Fusamoto, H., & Kamada, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2483 · Cited by 173
Vignaux, F., & Golstein, P. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240421 · Cited by 151
gld/gld mice are unable to express a functional ligand for Fas
Ramsdell, F., Seaman, M. S., Miller, R. E., Tough, T. W., Alderson, M. R., & Lynch, D. H. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240422 · Cited by 139
Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver
Benedetti, A., Jézéquel, A. M., & Orlandi, F. (1988) · Journal of Hepatology · doi:10.1016/s0168-8278(88)80004-7 · Cited by 88
Gillette‐Ferguson, I., & Sidman, C. L. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240526 · Cited by 80
Cell-mediated cytotoxicity: contact and secreted factors
Apasov, S. G., Redegeld, F. A., & Sitkovsky, M. V. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90060-6 · Cited by 69
Historical patterns of prolonged hepatitis C infection
Roberts, J. M., Searle, J. W., & Cooksley, W. G. E. (1993) · Gastroenterologia Japonica · doi:10.1007/bf02989202 · Cited by 58
Bosch, F. X., Udvarhelyi, N., Venter, E. H., Herold‐Mende, C. C., Schuhmann, A., Maier, H., Weidauer, H., & Born, A. I. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90020-g · Cited by 46
Hepatitis B Virus Biology and Pathogenesis
Chisari, F. V. (1992) · Elsevier eBooks · doi:10.1016/b978-0-12-462002-5.50008-x · Cited by 37
Cited by
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Self-citationTRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
Walczak, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5386 · Cited by 1,130
Self-citationRNA interference targeting Fas protects mice from fulminant hepatitis
Song, E., Lee, S.-K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,110
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
Lenardo, M., Chan, F. K.-M., Hornung, F., McFarland, H., Siegel, R., Wang, J., & Zheng, L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.221 · Cited by 943
Metadata
- Authors
- Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., & Runkel, L.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-11-01
- Volume
- 182
- Issue
- 5
- Pages
- 1223-1230
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2161261662
- Cited by
- 692
- References
- 44
- FWCI
- 13.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.